Labelle M. Role of the aberrantly expressed vascular endothelial cadherin in aggressive breast tumor cells: Diss. ... Dr. rer. nat (Dresden, 2007). - ОГЛАВЛЕНИЕ / CONTENTS
Навигация

Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
ОбложкаLabelle M. Role of the aberrantly expressed vascular endothelial cadherin in aggressive breast tumor cells: Diss. ... Dr. rer. nat. - Dresden: Techn. Univ., 2007. - 123 p.: ill., graph. - Ref.: p.110-123.
 

Оглавление / Contents
 
1  Declaration .................................................. 3
2  Abstract ..................................................... 4
3  Contents ..................................................... 6
4  Introduction ................................................. 9
   4.1  Preface ................................................. 9
   4.2  Tumor progression and metastasis ....................... 11
   4.3  Epithelial-mesenchymal transition in cancer ............ 14
        4.3.1  Markers of EMT .................................. 16
        4.3.2  Regulators of EMT ............................... 17
   4.4  TGF-β .................................................. 20
        4.4.1  TGF-β signaling pathway ......................... 21
               4.4.1.1  TGF-β activation ....................... 21
               4.4.1.2  Canonical TGF-β/Smads signaling
                        pathway ................................ 22
        4.4.2  Specificity in TGF-β signal transduction ........ 24
        4.4.3  TGF-β signaling crosstalk ....................... 25
               4.4.3.1  Smad-independent TGF-β signaling ....... 25
               4.4.3.2  Regulation of Smad activity by kinase
                        pathways ............................... 27
        4.4.4  TGF-β in cancer ................................. 27
               4.4.4.1  TGF-β acts as a tumor suppressor ....... 28
               4.4.4.2  TGF-β promotes tumor progression and
                        EMT .................................... 28
   4.5  Cadherins .............................................. 30
        4.5.1  Stucture and function ........................... 31
        4.5.2  VE-cadherin ..................................... 33
               4.5.2.1  Role of VE-cadherin in signal
                        transduction ........................... 34
               4.5.2.2  Control of VE-cadherin expression in
                        endothelial cells ...................... 35
        4.5.3  Cadherin switch in tumor progression and EMT .... 36
   4.6  Aims of the study ...................................... 38
   4.7  Experimental model ..................................... 39
5  Results ..................................................... 42
   5.1  VE-cadherin is expressed in aggressive tumor cells ..... 42
        5.1.1  VE-cadherin is expressed in aggressive tumor
               cells in vitro .................................. 42
        5.1.2  VE-cadherin expression is induced during
               TGF-β1-mediated EMT in vitro .................... 44
        5.1.3  VE-cadherin is expressed in aggressive tumor
               cells in vivo ................................... 47
        5.1.4  VE-cadherin is expressed in human mammary
               tumor cells ..................................... 49
   5.2  VE-cadherin expression influences tumor cell behavior
        in vitro as well as in vivo ............................ 51
        5.2.1  VE-cadherin expression promotes proliferation
               of Ep5ExTu cells ................................ 51
        5.2.2  VE-cadherin expression promotes cord-like
               structures formation by Ep5ExTu cells ........... 54
        5.2.3  VE-cadherin expression promotes Ep5ExTu cell
               adhesion to endothelial cells ................... 55
        5.2.4  VE-cadherin expression affects N-cadherin
               localization in Ep5ExTu cells ................... 55
        5.2.5  Isolation of tumor cell lines with stable
               knock-down of VE-cadherin ....................... 57
        5.2.6  VE-cadherin suppression reduces Ep5ExTu cell
               proliferation in vitro .......................... 60
        5.2.7  VE-cadherin suppression reduces tumor growth
               in vivo ......................................... 61
        5.2.8  Stable suppression of VE-cadherin affects
               Ep5ExTu cell morphology and expression of
               EMT-related genes ............................... 61
   5.3  Characterization of the molecular mechanism by which
        VE-cadherin affects tumor cell behavior ................ 64
        5.3.1  Stable suppression of VE-cadherin
               downregulates Smad2 phosphorylation and TGF-β
               target gene expression in Ep5ExTu cells ......... 64
        5.3.2  Inhibition of the TGF-β pathway reduces
               Ep5ExTu cell proliferation ...................... 68
   5.4  Summary of results ..................................... 69
6  Discussion .................................................. 70
   6.1  VE-cadherin is expressed in aggressive tumor cells ..... 70
        6.1.1  VE-cadherin expression during tumor
               progression and EMT ............................. 70
        6.1.2  VE-cadherin is expressed in tumor cells in
               vivo ............................................ 73
   6.2  VE-cadherin expression influences tumor cell
        behavior ............................................... 75
   6.3  Characterization of the molecular mechanism by which
        VE-cadherin affects tumor cell behavior ................ 81
        6.3.1  VE-cadherin promotes Smad2 phosphorylation and
               TGF-β target gene expression .................... 82
               6.3.1.1  Smad2 phosphorylation .................. 82
               6.3.1.2  Snail and Slug expression .............. 82
               6.3.1.3  PAI-1 expression ....................... 83
               6.3.1.4  MMP-9 expression ....................... 83
               6.3.1.5  Evaluation of the possible
                        contribution of other signaling
                        pathways ............................... 84
        6.3.2  The  effects of VE-cadherin suppression on
               tumor growth and cell morphology are
               consistent with an inhibition of the TGF-β
               pathway ......................................... 85
        6.3.3  Inhibition of the TGF-β pathway reduces
               Ep5ExTu cell proliferation ...................... 85
   6.4  VE-cadherin as a target for anti-tumor therapies ....... 87
   6.5  Conclusion ............................................. 88
7  Material and methods ........................................ 90
   7.1  Cell culture ........................................... 90
   7.2  Generation of lentiviral vectors ....................... 90
        7.2.1  Vector design and cloning ....................... 92
        7.2.2  Lentiviral vector production .................... 94
        7.2.3  Replication test ................................ 94
        7.2.4  Titer determination ............................. 95
   7.3  Lentiviral transduction of target cells and
        generation of stable cell lines ........................ 95
   7.4  Mouse tumor model ...................................... 96
   7.5  Microarray analysis .................................... 97
   7.6  Transcient transfection with siRNA ..................... 97
   7.7  RNA isolation and Reverse Transcriptase (RT)-PCR
        analysis ............................................... 98
   7.8  Preparation of cell lysates ............................ 99
   7.9  Determination of protein concentration ................. 99
   7.10 Immunoblot analysis .................................... 99
   7.11 Immunoprecipitation ................................... 100
   7.12 Fluorescence activated cell sorting (FACS) analysis ... 101
   7.13 Immunofluorescence staining of tissue culture cells ... 102
   7.14 Immunohistochemistry and immunofluorescence on
        frozen tumor sections ................................. 102
   7.15 Immunohistochemistry on paraffin-embedded tumor
        sections .............................................. 103
   7.16 Proliferation assay ................................... 103
   7.17 Cord-like structure formation in collagen gel ......... 104
   7.18 Adhesion assay ........................................ 104
   7.19 Invasion assay ........................................ 105
   7.20 Zymography ............................................ 105
   7.21 Statistics ............................................ 106
8  Acknowledgements ........................................... 107
9  Publication ................................................ 108
10 References ................................................. 110


Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
 

[О библиотеке | Академгородок | Новости | Выставки | Ресурсы | Библиография | Партнеры | ИнфоЛоция | Поиск]
  Пожелания и письма: branch@gpntbsib.ru
© 1997-2024 Отделение ГПНТБ СО РАН (Новосибирск)
Статистика доступов: архив | текущая статистика
 

Документ изменен: Wed Feb 27 14:22:30 2019. Размер: 12,387 bytes.
Посещение N 1599 c 23.08.2011